Ramalingam, S., Pérol, M., Reck, M., Kowalyszyn, R., Gautschi, O., Kimmich, M., … Garon, E. (2017). Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2017.12.011 (Original work published 2017)